179 related articles for article (PubMed ID: 29317220)
1. Acamprosate rescues neuronal defects in the Drosophila model of Fragile X Syndrome.
Hutson RL; Thompson RL; Bantel AP; Tessier CR
Life Sci; 2018 Feb; 195():65-70. PubMed ID: 29317220
[TBL] [Abstract][Full Text] [Related]
2. Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.
Siller SS; Broadie K
Dis Model Mech; 2011 Sep; 4(5):673-85. PubMed ID: 21669931
[TBL] [Abstract][Full Text] [Related]
3. Wnd/DLK Is a Critical Target of FMRP Responsible for Neurodevelopmental and Behavior Defects in the Drosophila Model of Fragile X Syndrome.
Russo A; DiAntonio A
Cell Rep; 2019 Sep; 28(10):2581-2593.e5. PubMed ID: 31484070
[TBL] [Abstract][Full Text] [Related]
4. Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.
Coffee RL; Tessier CR; Woodruff EA; Broadie K
Dis Model Mech; 2010; 3(7-8):471-85. PubMed ID: 20442204
[TBL] [Abstract][Full Text] [Related]
5. Hyperactive locomotion in a
Kashima R; Redmond PL; Ghatpande P; Roy S; Kornberg TB; Hanke T; Knapp S; Lagna G; Hata A
Sci Signal; 2017 May; 10(477):. PubMed ID: 28465421
[TBL] [Abstract][Full Text] [Related]
6. In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation.
Coffee RL; Williamson AJ; Adkins CM; Gray MC; Page TL; Broadie K
Hum Mol Genet; 2012 Feb; 21(4):900-15. PubMed ID: 22080836
[TBL] [Abstract][Full Text] [Related]
7. Temporal requirements of the fragile X mental retardation protein in the regulation of synaptic structure.
Gatto CL; Broadie K
Development; 2008 Aug; 135(15):2637-48. PubMed ID: 18579676
[TBL] [Abstract][Full Text] [Related]
8.
Trajković J; Makevic V; Pesic M; Pavković-Lučić S; Milojevic S; Cvjetkovic S; Hagerman R; Budimirovic DB; Protic D
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672829
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
[TBL] [Abstract][Full Text] [Related]
10. Bisphenol F affects neurodevelopmental gene expression, mushroom body development, and behavior in Drosophila melanogaster.
Fishburn JLA; Larson HL; Nguyen A; Welch CJ; Moore T; Penn A; Newman J; Mangino A; Widman E; Ghobashy R; Witherspoon J; Lee W; Mulligan KA
Neurotoxicol Teratol; 2024; 102():107331. PubMed ID: 38301979
[TBL] [Abstract][Full Text] [Related]
11. Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.
Erickson CA; Wink LK; Ray B; Early MC; Stiegelmeyer E; Mathieu-Frasier L; Patrick V; Lahiri DK; McDougle CJ
Psychopharmacology (Berl); 2013 Jul; 228(1):75-84. PubMed ID: 23436129
[TBL] [Abstract][Full Text] [Related]
12. Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model.
Monyak RE; Emerson D; Schoenfeld BP; Zheng X; Chambers DB; Rosenfelt C; Langer S; Hinchey P; Choi CH; McDonald TV; Bolduc FV; Sehgal A; McBride SMJ; Jongens TA
Mol Psychiatry; 2017 Aug; 22(8):1140-1148. PubMed ID: 27090306
[TBL] [Abstract][Full Text] [Related]
13. Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker.
Erickson CA; Ray B; Maloney B; Wink LK; Bowers K; Schaefer TL; McDougle CJ; Sokol DK; Lahiri DK
J Psychiatr Res; 2014 Dec; 59():220-8. PubMed ID: 25300441
[TBL] [Abstract][Full Text] [Related]
14. MiR-219 represses expression of dFMR1 in Drosophila melanogaster.
Wang C; Ge L; Wu J; Wang X; Yuan L
Life Sci; 2019 Feb; 218():31-37. PubMed ID: 30528775
[TBL] [Abstract][Full Text] [Related]
15. The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein pickpocket1.
Xu K; Bogert BA; Li W; Su K; Lee A; Gao FB
Curr Biol; 2004 Jun; 14(12):1025-34. PubMed ID: 15202995
[TBL] [Abstract][Full Text] [Related]
16. Argonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects.
Pepper AS; Beerman RW; Bhogal B; Jongens TA
PLoS One; 2009 Oct; 4(10):e7618. PubMed ID: 19888420
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous motor-behavior abnormalities in two
Andrew DR; Moe ME; Chen D; Tello JA; Doser RL; Conner WE; Ghuman JK; Restifo LL
J Neurogenet; 2021 Mar; 35(1):1-22. PubMed ID: 33164597
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate receptor-mediated use-dependent down-regulation of synaptic excitability involves the fragile X mental retardation protein.
Repicky S; Broadie K
J Neurophysiol; 2009 Feb; 101(2):672-87. PubMed ID: 19036865
[TBL] [Abstract][Full Text] [Related]
19. Brief report: acamprosate in fragile X syndrome.
Erickson CA; Mullett JE; McDougle CJ
J Autism Dev Disord; 2010 Nov; 40(11):1412-6. PubMed ID: 20213249
[TBL] [Abstract][Full Text] [Related]
20. GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model.
Gatto CL; Pereira D; Broadie K
Neurobiol Dis; 2014 May; 65():142-59. PubMed ID: 24423648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
